Tidal Investments’s Cidara Therapeutics CDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,649
Closed -$254K 2164
2025
Q3
$254K Buy
+2,649
New +$169K ﹤0.01% 1870

Other funds holding CDTX

Tidal Investments's CDTX Position: Q4 2025 in Review

Tidal Investments sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 2,649 shares — an estimated $254K sold.

Tidal Investments first reported a position in CDTX in Q3 2025 and held it in 1 quarter. The position peaked at $254K in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

  • Tidal Investments reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tidal Investments sold 2,649 Cidara Therapeutics shares in Q4 2025, an estimated $254K.
  • Tidal Investments first reported a position in Cidara Therapeutics in Q3 2025 and held it in 1 quarter.
  • Tidal Investments's Cidara Therapeutics position peaked at $254K in Q3 2025.
  • 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on Tidal Investments's 13F filing for Q4 2025, filed 13 Feb 2026.